Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minesh Patel

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Bioanalysis|August 3, 2017
Best practices in performing flow cytometry in a regulated environment: feedback from experience within the European Bioanalysis ForumBarry van der Strate, Robin Longdin, Marie Geerlings, et al.
Journal for Immunotherapy of Cancer|April 24, 2023
Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE)Marwan Fakih, Wael Harb, Daruka Mahadevan, et al.
American Heart Journal|February 3, 2015
Changes in mid-life fitness predicts heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: the Cooper Center Longitudinal StudyAmbarish Pandey, Minesh Patel, Ang Gao, et al.
Plant Biotechnology Journal|December 10, 2014
Overexpression of ubiquitin-like LpHUB1 gene confers drought tolerance in perennial ryegrassMinesh Patel, Susana Milla-Lewis, Wanjun Zhang, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 25, 2025
Neuroadaptation in neurodegenerative diseases: compensatory mechanisms and therapeutic approachesSpandana Rajendra Kopalli, Tapan Behl, Lalji Baldaniya, et al.
British Journal of Clinical Pharmacology|December 20, 2018
Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti-CD3ε mAb in new-onset type 1 diabetes mellitus patientsGeorgios Vlasakakis, Antonella Napolitano, Ruth Barnard, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Bioanalysis|August 3, 2017
Best practices in performing flow cytometry in a regulated environment: feedback from experience within the European Bioanalysis ForumBarry van der Strate, Robin Longdin, Marie Geerlings, et al.
Journal for Immunotherapy of Cancer|April 24, 2023
Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE)Marwan Fakih, Wael Harb, Daruka Mahadevan, et al.
American Heart Journal|February 3, 2015
Changes in mid-life fitness predicts heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: the Cooper Center Longitudinal StudyAmbarish Pandey, Minesh Patel, Ang Gao, et al.
Plant Biotechnology Journal|December 10, 2014
Overexpression of ubiquitin-like LpHUB1 gene confers drought tolerance in perennial ryegrassMinesh Patel, Susana Milla-Lewis, Wanjun Zhang, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 25, 2025
Neuroadaptation in neurodegenerative diseases: compensatory mechanisms and therapeutic approachesSpandana Rajendra Kopalli, Tapan Behl, Lalji Baldaniya, et al.
British Journal of Clinical Pharmacology|December 20, 2018
Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti-CD3ε mAb in new-onset type 1 diabetes mellitus patientsGeorgios Vlasakakis, Antonella Napolitano, Ruth Barnard, et al.
Pageof 3